UC Davis Hemophilia Treatment Center is a clinical research site located in Sacramento, California, United States 95817.
Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.
UC Davis Hemophilia Treatment Center has participated in 4 clinical trials with 2 currently active.
Therapeutic areas: Hemophilia A, Hemophilia B.
Sponsors: BioMarin Pharmaceutical, Pfizer.
Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
UC Davis Hemophilia Treatment Center has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
UC Davis Hemophilia Treatment Center has 4 clinical trials on record, with 2 currently active. Their work covers Hemophilia A, Hemophilia B.
UC Davis Hemophilia Treatment Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.